Through manipulating the patent system, pharmaceutical companies are able to extend patent protection and potentially the market monopoly on their most profitable drugs
Access this article Similar content being viewed by others References Cooper AJ, Gupta SR, Moustafa AF, Chao AM
doi: 10.3390/molecules27134315
The highest dose studied in Phase 2, producing up to 24.2% average weight loss at 48 weeks
Estos frmacos, diseados para imitar la accin del pptido similar al glucagn tipo 1 (GLP-1, una hormona natural que regula el apetito y el control de la glucosa), han emergido como una herramienta prometedora en la lucha contra la obesidad
Long non-Coding RNA lnc-CCNL1-3:1 Promotes Granulosa Cell Apoptosis and Suppresses Glucose Uptake in Women With Polycystic Ovary Syndrome